✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹23 Cr.
P/E
26.16
  • Ishita Drugs & Inds.
  • Zenith Health Care
  • iStreet Network
FAQs on Ishita Drugs & Industries Ltd. Shareprice

Ishita Drugs & Inds. has given better returns compared to its competitors.
Ishita Drugs & Inds. has grown at ~21.26% over the last 4yrs while peers have grown at a median rate of 6.58%

Yes, Ishita Drugs & Inds. is expensive.
Latest PE of Ishita Drugs & Inds. is 26.16, while 3 year average PE is 24.05.
Also latest EV/EBITDA of Ishita Drugs & Inds. is 22.03 while 3yr average is 15.94.

Growth Table
  • Ishita Drugs & Industries Ltd.
  • Zenith Health Care
  • iStreet Network
* Share price and PE growth are updated everyday. All other fields are as of latest financial year end. EPS adjusted for bonus and splits.
Balance Sheet
  • Ishita Drugs & Industries Ltd.
  • Zenith Health Care
  • iStreet Network
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Ishita Drugs & Industries Ltd.
  • Zenith Health Care
  • iStreet Network
TTM Values as of Mar 2025
Cash Flow
  • Ishita Drugs & Industries Ltd.
  • Zenith Health Care
  • iStreet Network
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Ishita Drugs & Industries Ltd.
  • Zenith Health Care
  • iStreet Network
Quarterly Results
  • Ishita Drugs & Industries Ltd.
  • Zenith Health Care
  • iStreet Network
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
35.00%
Implied Growth Rate over a 5 year period*
12.00%
Implied Growth Rate over a 10 year period*
5.00%
Implied Growth Rate over a 20 year period*
FAQs on Ishita Drugs & Industries Ltd. Financials

Balance sheet of Ishita Drugs & Inds. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Ishita Drugs & Inds. is increasing.
Latest net debt of Ishita Drugs & Inds. is -₹0.93 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹9.25 Crs.

Yes, profit is increasing.
The profit of Ishita Drugs & Inds. is ₹0.87 Crs for TTM, ₹0.75 Crs for Mar 2024 and ₹0.58 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ishita Drugs & Inds. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech